Medeon Biodesign, Inc.

Medeon Biodesign, Inc. is a healthcare company specializing in the research, development, manufacture, and sale of medical devices. Established in 2012 and headquartered in Taipei, the company is recognized for its focus on innovative solutions for minimally invasive surgeries. Its core portfolio includes advanced instruments used in laparoscopic and cardiac catheterization procedures, such as vascular closure systems, orthopedic treatment devices, tools for addressing benign prostatic hyperplasia, and specialized equipment to enhance laparoscopic visibility and safety. Medeon Biodesign also provides contract manufacturing for medical devices and produces injection-molded components that support its product range. Serving both domestic and international markets, the company's technologies contribute to significant improvements in surgical outcomes, patient recovery, and operational efficiency in hospitals and clinics. Medeon Biodesign plays an integral role in the broader medical technology and devices sector by advancing procedural efficacy and expanding global access to modern, less invasive surgical treatments.